Inventor · disambiguated record
Douglas Kim Graham
Also filed as: GRAHAM DOUGLAS · GRAHAM DOUGLAS K · GRAHAM DOUGLAS KIM
7 granted patents·5 pending applications·31 citations·filing 2005–2017
82Inventor score
Top patents by PatentIndex Score
12 records- 0185US9574337B1Flow control methods and devicesLANE ENTPR INC·Filed 2013·Granted Feb 21, 2017·10 cites·19 claims
- 0278US8168415B2Axl fusion proteins as Axl tyrosine kinase inhibitorsGRAHAM DOUGLAS KIM·Filed 2008·Granted May 1, 2012·7 cites·6 claims
- 0371US9309989B1Flow control deviceLANE ENTPR INC·Filed 2013·Granted Apr 12, 2016·3 cites·21 claims
- 0471US9290923B1Flow control device for a storm water management systemLANE ENTPR INC·Filed 2013·Granted Mar 22, 2016·5 cites·23 claims
- 0568US8920799B2Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domainGRAHAM DOUGLAS KIM·Filed 2012·Granted Dec 30, 2014·1 cites·15 claims
- 0666US8974387B2Analyte testing method and device for diabetes managementSHADFORTH IAN·Filed 2010·Granted Mar 10, 2015·5 cites·4 claims
- 0751US2015184137A1Axl tyrosine kinase inhibitors and methods of making and using the sameGRAHAM DOUGLAS KIM·Filed 2014·Application pending·0 cites
- 0845US2008267975A1Mer Diagnostic and Therapeutic AgentsUNIV COLORADO·Filed 2005·Application pending·0 cites
- 0944US10709708B2Method of treating cancer with a combination of MER tyrosine kinase inhibitor and an epidermal growth factor receptor (EGFR) inhibitorUNIV EMORY·Filed 2017·Granted Jul 14, 2020·0 cites·9 claims
- 1043US2012230991A1Methods and compounds for enhancing anti-cancer therapyGRAHAM DOUGLAS KIM·Filed 2009·Application pending·0 cites
- 1139US2012135424A1Mer diagnostic and therapeutic agentsGRAHAM DOUGLAS KIM·Filed 2011·Application pending·0 cites
- 1238US2017202847A1Methods for the treatment of tumorsUNIV NORTH CAROLINA CHAPEL HILL·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Douglas Kim Graham files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →